BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang XF, Liu PY, Zhang SJ, Zhao KL, Zhao WX. Principle and progress of radical treatment for locally advanced esophageal squamous cell carcinoma. World J Clin Cases 2022; 10(35): 12804-12811 [PMID: 36569017 DOI: 10.12998/wjcc.v10.i35.12804]
URL: https://www.wjgnet.com/2307-8960/full/v10/i35/12804.htm
Number Citing Articles
1
Yong Chen, Shuangmei Zhu, Xiang Lan, Tianzhen Hu, Lele Ma, Hong Ye, Baoqiang Wang, Xiao He, Hanying Wang, Pranshu Sahgal. The Neoadjuvant Administration of PD‐1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous‐Cell CarcinomaJournal of Clinical Pharmacy and Therapeutics 2024; 2024(1) doi: 10.1155/2024/5542947
2
Yusheng Pan. Clinical effectiveness and safety of Camrelizumab immunotherapy in treating advanced esophageal carcinomaAmerican Journal of Translational Research 2024; 16(10): 5880 doi: 10.62347/KMCL5401
3
Xiuli Xia, Shushan Zhao, Wenting Chen, Chao Xu, Dongqiang Zhao. CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathwayIrish Journal of Medical Science (1971 -) 2023; 192(6): 2653 doi: 10.1007/s11845-023-03357-y
4
Shuang He, Liu E, Fei Chen, Zhidong Li. SCCGs_Prediction: a machine learning tool for prediction of sulfur-containing compound associated genesTropical Plants 2023; 2(1): 0 doi: 10.48130/TP-2023-0018